Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 352,073 | 310,785 | 443,019 | 677,475 | -- |
| General And Administrative Expense | 321,767 | 261,543 | 385,939 | 596,336 | -- |
| Other Operating Expenses | 173,476 | 178,411 | 193,030 | 209,071 | -- |
| Operating Expense | 525,549 | 489,196 | 636,049 | 886,546 | -- |
| Operating Income | -525,549 | -489,196 | -636,049 | -886,546 | -- |
| EBIT | -525,549 | -489,196 | -636,049 | -886,546 | -- |
| Other Income Expense | -25,780 | 2,484 | -5.5M | -- | 37,481 |
| Other Non Operating Income Expenses | -- | 75,956 | 31,605 | -- | 110,863 |
| Special Income Charges | -15,947 | -52,472 | -5.5M | 0.00 | -- |
| Write Off | -- | -- | -- | -- | -74,393 |
| Gain On Sale Of Security | -9,833 | -21,000 | -- | -- | -- |
| Pretax Income | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Net Income From Continuing Operation Net Minority Interest | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Net Income Including Noncontrolling Interests | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Net Income Common Stockholders | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Net Income | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| EBITDA | -525,549 | -489,196 | -636,049 | -886,546 | -- |
| Normalized EBITDA | -499,769 | -415,724 | 4.9M | -886,546 | -- |
| Basic EPS | -0.01 | -0.01 | -0.20 | -0.03 | -- |
| Diluted EPS | -0.01 | -0.01 | -0.20 | -0.03 | -- |
| Basic Average Shares | 54.8M | 42.4M | 30.9M | 25.4M | -- |
| Diluted Average Shares | 54.8M | 42.4M | 30.9M | 25.4M | -- |
| Total Unusual Items | -25,780 | -73,472 | -5.5M | 0.00 | -- |
| Total Unusual Items Excluding Goodwill | -25,780 | -73,472 | -5.5M | 0.00 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -525,549 | -413,240 | -604,444 | -886,546 | -- |
| Diluted NI Availto Com Stockholders | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Gain On Sale Of Ppe | 0.00 | -47,972 | -- | -- | -- |
| Impairment Of Capital Assets | 15,947 | 4,500 | 5.5M | 0.00 | -- |
| Net Income Continuous Operations | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Other Gand A | 230,467 | 261,543 | 260,739 | 266,236 | -- |
| Other Special Charges | -- | -- | -15,458 | -- | -- |
| Salaries And Wages | 91,300 | 0.00 | 125,200 | 330,100 | -- |
| Selling And Marketing Expense | 30,306 | 49,242 | 57,080 | 81,139 | -- |
| Total Expenses | 525,549 | 489,196 | 636,049 | 886,546 | -- |
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 22,211 | 189,790 | 3,053 | 1,681 | -- |
| Cash Cash Equivalents And Short Term Investments | 69,711 | 350,790 | 3,053 | 1,681 | -- |
| Cash Financial | 22,211 | 189,790 | 3,053 | 1,681 | -- |
| Other Short Term Investments | 47,500 | 161,000 | 0.00 | -- | -- |
| Accounts Receivable | 9,863 | 30,567 | 25,176 | 6,250 | -- |
| Receivables | 9,863 | 30,567 | 25,176 | 6,250 | -- |
| Prepaid Assets | 925.00 | 3,300 | 8,443 | 5,320 | -- |
| Current Assets | 80,499 | 384,657 | 36,672 | 13,251 | -- |
| Net PPE | 637,346 | 644,506 | 392,880 | 5.3M | -- |
| Other Non Current Assets | -- | -- | -- | -- | 12,000 |
| Total Non Current Assets | 638,893 | 644,506 | 542,445 | 5.3M | -- |
| Total Assets | 719,392 | 1.0M | 579,117 | 5.4M | -- |
| Current Debt | 2,500 | -- | 5,000 | -- | -- |
| Current Debt And Capital Lease Obligation | 2,500 | -- | 5,000 | -- | -- |
| Accounts Payable | 200,403 | 107,045 | 40,770 | 70,253 | -- |
| Payables | 200,403 | 107,045 | 40,770 | 70,253 | -- |
| Payables And Accrued Expenses | 344,403 | 209,045 | 94,770 | 148,379 | -- |
| Current Accrued Expenses | 144,000 | 102,000 | 54,000 | 78,126 | -- |
| Current Liabilities | 346,903 | 209,045 | 99,770 | 148,379 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 346,903 | 209,045 | 99,770 | 148,379 | -- |
| Common Stock | 20.3M | 20.3M | 19.5M | 18.3M | -- |
| Capital Stock | 20.3M | 20.3M | 19.5M | 18.3M | -- |
| Retained Earnings | -22.9M | -22.3M | -21.8M | -15.7M | -- |
| Gains Losses Not Affecting Retained Earnings | 3.0M | 2.9M | 2.8M | 2.7M | -- |
| Common Stock Equity | 372,489 | 820,118 | 479,347 | 5.2M | -- |
| Stockholders Equity | 372,489 | 820,118 | 479,347 | 5.2M | -- |
| Total Equity Gross Minority Interest | 372,489 | 820,118 | 479,347 | 5.2M | -- |
| Total Capitalization | 372,489 | 820,118 | 479,347 | 5.2M | -- |
| Net Tangible Assets | 372,489 | 820,118 | 479,347 | 5.2M | -- |
| Tangible Book Value | 372,489 | 820,118 | 479,347 | 5.2M | -- |
| Working Capital | -266,404 | 175,612 | -63,098 | -135,128 | -- |
| Invested Capital | 374,989 | 820,118 | 484,347 | 5.2M | -- |
| Total Debt | 2,500 | -- | 5,000 | -- | -- |
| Net Debt | -- | -- | 1,947 | -- | -- |
| Share Issued | 55.0M | 54.6M | 37.6M | 25.7M | -- |
| Ordinary Shares Number | 55.0M | 54.6M | 37.6M | 25.7M | -- |
| Non Current Prepaid Assets | 1,547 | 0.00 | 149,565 | 0.00 | -- |
| Other Current Borrowings | 2,500 | -- | 5,000 | -- | -- |
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -281,697 | -341,075 | -527,649 | -437,246 | -- |
| Cash Flow From Continuing Operating Activities | -281,697 | -341,075 | -527,649 | -437,246 | -- |
| Stock Based Compensation | 91,300 | 0.00 | 125,200 | 330,100 | -- |
| Change In Working Capital | 152,552 | 109,732 | -32,947 | 119,200 | -- |
| Change In Receivables | 20,704 | -5,391 | -18,926 | 34,499 | -- |
| Change In Payables And Accrued Expense | 129,473 | 109,980 | -10,898 | 65,021 | -- |
| Other Non Cash Items | -- | -37,567 | -15,458 | -- | -17,468 |
| Capital Expenditure | -26,468 | -40,853 | -252,298 | -43,669 | -- |
| Purchase Of PPE | -26,468 | -40,853 | -252,298 | -43,669 | -- |
| Net PPE Purchase And Sale | -26,468 | 34,147 | -252,298 | -43,669 | -- |
| Sale Of Investment | 103,667 | 0.00 | -- | -- | -- |
| Net Investment Purchase And Sale | 103,667 | 0.00 | -- | -- | -- |
| Investing Cash Flow | 111,618 | -119,488 | -437,479 | -643,717 | -- |
| Cash Flow From Continuing Investing Activities | 111,618 | -119,488 | -437,479 | -643,717 | -- |
| Issuance Of Debt | 12,500 | 50,000 | 5,000 | -- | -- |
| Repayment Of Debt | -10,000 | -55,000 | 0.00 | -- | -- |
| Net Issuance Payments Of Debt | 2,500 | -5,000 | 5,000 | 0.00 | -- |
| Issuance Of Capital Stock | 0.00 | 683,300 | 988,200 | 0.00 | -- |
| Net Common Stock Issuance | 0.00 | 683,300 | 988,200 | 0.00 | -- |
| Financing Cash Flow | 2,500 | 647,300 | 966,500 | 71,500 | -- |
| Cash Flow From Continuing Financing Activities | 2,500 | 647,300 | 966,500 | 71,500 | -- |
| Changes In Cash | -167,579 | 186,737 | 1,372 | -1.0M | -- |
| Beginning Cash Position | 189,790 | 3,053 | 1,681 | 1.0M | -- |
| End Cash Position | 22,211 | 189,790 | 3,053 | 1,681 | -- |
| Free Cash Flow | -308,165 | -381,928 | -779,947 | -480,915 | -- |
| Asset Impairment Charge | 15,947 | 4,500 | 5.5M | 0.00 | -- |
| Change In Prepaid Assets | 2,375 | 5,143 | -3,123 | 19,680 | -- |
| Common Stock Issuance | 0.00 | 683,300 | 988,200 | 0.00 | -- |
| Gain Loss On Investment Securities | 16,583 | -- | -- | -- | -- |
| Gain Loss On Sale Of PPE | 0.00 | 47,972 | 0.00 | -- | -- |
| Net Foreign Currency Exchange Gain Loss | -- | -- | -- | -- | 0.00 |
| Net Income From Continuing Operations | -551,329 | -486,712 | -6.1M | -886,546 | -- |
| Net Other Financing Charges | -- | -31,000 | -26,700 | -- | -61,920 |
| Net Other Investing Changes | 34,419 | -153,635 | -185,181 | -600,048 | -- |
| Net Short Term Debt Issuance | 2,500 | -5,000 | 5,000 | 0.00 | -- |
| Operating Gains Losses | 16,583 | 47,972 | -- | -- | -- |
| Proceeds From Stock Option Exercised | -- | -- | 0.00 | 71,500 | 1.1M |
| Sale Of PPE | 0.00 | 75,000 | 0.00 | -- | -- |
| Short Term Debt Issuance | 12,500 | 50,000 | 5,000 | -- | -- |
| Short Term Debt Payments | -10,000 | -55,000 | 0.00 | -- | -- |
| Unrealized Gain Loss On Investment Securities | -6,750 | 21,000 | 0.00 | -- | -- |